Table 3.
Characteristics and Natural History of 225 CRE-Colonized Patients
| Characteristics | N (%) |
|---|---|
| Site of CRE colonization | |
| ● Urine | 137 (60.9%) |
| ● Sputum | 95 (42.2%) |
| ● Body fluid | 21 (9.3%) |
| ● Tissue | 9 (1.3%) |
| Presence of CRE in stool or rectal swab samples at enrollment of study patients | 152 (67.6%) |
| Status of 225 patients with CRE colonization during hospitalization | |
| ● Developed CRE infection | 46 (20.4%) |
| ● Site of CRE infection in 46 patients | |
| ● HAP/VAP | 20 (43.5%) |
| ● Urinary tract infection | 14 (30.4%) |
| ● Catheter-related blood stream infection | 5 (10.8%) |
| ● Intra-abdominal infection | 3 (6.5%) |
| ● Primary bacteremia | 2 (4.3%) |
| ● Skin and soft tissue infection | 2 (4.3%) |
| ● No CRE infection | 179 (79.6%) |
| ● CRE status at discharge of 69 patients who had ≥2 stool or rectal swab samples collected and had CRE in the initial stool or rectal swab sample | |
| ● Absence of CRE colonization before discharge | 18 (26.1%) |
| ● Presence of CRE colonization before discharge | 51 (73.9%) |
Abbreviations: CRE, carbapenem-resistant Enterobacterales; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia.